PLGA-Based Nanoparticles in Cancer Treatment

• Sima Rezvantalab,
• Sima Rezvantalab,
• Natascha Ingrid Drude,
• Natascha Ingrid Drude,
• Mostafa Keshavarz Moraveji,
• Nihan Güvener,
• Emily Kate Koons,
• Yang Shi,
• Twan Lammers,
• Fabian Kiessling

Affiliations

Sima Rezvantalab

Department of Chemical Engineering, Amirkabir University of Technology (Tehran Polytechnic), Tehran, Iran

Sima Rezvantalab

Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany

Natascha Ingrid Drude

Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany

Natascha Ingrid Drude

Department of Nuclear Medicine, Uniklinik RWTH Aachen University, Aachen, Germany

Mostafa Keshavarz Moraveji

Department of Chemical Engineering, Amirkabir University of Technology (Tehran Polytechnic), Tehran, Iran

Nihan Güvener

Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany

Emily Kate Koons

Department of Pharmacology and Toxicology, College of Pharmacy & UA Cancer Center, University of Arizona, Tucson, AZ, United States

Yang Shi

Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany

Twan Lammers

Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany

Fabian Kiessling

Institute for Experimental Molecular Imaging, University Clinic and Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany